Literature DB >> 7506046

Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons.

M S Rao1, Y Sun, J L Escary, J Perreau, S Tresser, P H Patterson, R E Zigmond, P Brulet, S C Landis.   

Abstract

Leukemia inhibitory factor (LIF; also known as cholinergic differentiation factor) is a multifunctional cytokine that affects neurons, as well as many other cell types. To examine its neuronal functions in vivo, we have used LIF-deficient mice. In culture, LIF alters the transmitter phenotype of sympathetic neurons, inducing cholinergic function, reducing noradrenergic function, and altering neuropeptide expression. In vivo, a noradrenergic to cholinergic switch occurs in the developing sweat gland innervation, and changes in neuropeptide phenotype occur in axotomized adult ganglia. We find that the gland innervation of LIF-deficient mice is indistinguishable from normal. In contrast, neuropeptide induction in ganglia cultured as explants or axotomized in situ is significantly suppressed in LIF-deficient mice. Thus, LIF plays a role in transmitter changes induced by axotomy but not by developmental interactions with sweat glands.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506046     DOI: 10.1016/0896-6273(93)90229-k

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  53 in total

1.  Developmental changes in the transmitter properties of sympathetic neurons that innervate the periosteum.

Authors:  S E Asmus; S Parsons; S C Landis
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

2.  Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons.

Authors:  P G Murphy; L S Borthwick; R S Johnston; G Kuchel; P M Richardson
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

3.  gp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 and 2.

Authors:  Xiao Shi; Beth A Habecker
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

4.  Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms.

Authors:  Eric N Alston; Diana C Parrish; Wohaib Hasan; Kevin Tharp; Laura Pahlmeyer; Beth A Habecker
Journal:  Neuropeptides       Date:  2010-10-28       Impact factor: 3.286

5.  STAT3 integrates cytokine and neurotrophin signals to promote sympathetic axon regeneration.

Authors:  Michael J Pellegrino; Beth A Habecker
Journal:  Mol Cell Neurosci       Date:  2013-07-03       Impact factor: 4.314

Review 6.  Inflammation and axonal regeneration.

Authors:  P M Richardson; X Lu
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

Review 7.  The cellular and molecular basis of peripheral nerve regeneration.

Authors:  S Y Fu; T Gordon
Journal:  Mol Neurobiol       Date:  1997 Feb-Apr       Impact factor: 5.590

8.  A reciprocal cell-cell interaction mediated by NT-3 and neuregulins controls the early survival and development of sympathetic neuroblasts.

Authors:  J M Verdi; A K Groves; I Fariñas; K Jones; M A Marchionni; L F Reichardt; D J Anderson
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

9.  Post-infarct cardiac sympathetic hyperactivity regulates galanin expression.

Authors:  T Jarred Ewert; Kurt R Gritman; Michael Bader; Beth A Habecker
Journal:  Neurosci Lett       Date:  2008-03-18       Impact factor: 3.046

10.  Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents.

Authors:  Hideaki Kanazawa; Masaki Ieda; Kensuke Kimura; Takahide Arai; Haruko Kawaguchi-Manabe; Tomohiro Matsuhashi; Jin Endo; Motoaki Sano; Takashi Kawakami; Tokuhiro Kimura; Toshiaki Monkawa; Matsuhiko Hayashi; Akio Iwanami; Hideyuki Okano; Yasunori Okada; Hatsue Ishibashi-Ueda; Satoshi Ogawa; Keiichi Fukuda
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.